Colorectal cancer severity and survival in correlation with tumour necrosis factor-alpha

Biotechnology and Biotechnological Equipment

Volumn 28, Issue 5, 2014, Pages 911-917

  Stanilov, Noyko ^a,b   Miteva, Lyuba ^a   Dobreva, Zlatka ^a   Stanilova, Spaska ^a  

^a TRAKIA UNIVERSITY   (Bulgaria)

^b MILTON KEYNES GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cytokine production; Inflammation; Single nucleotide polymorphism; Tumour progression

Indexed keywords

BODY FLUIDS; GENES; PATHOLOGY; TUMORS;

COLORECTAL CANCERS (CRC); CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; INTESTINAL INFLAMMATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISMS; SINGLE NUCLEOTIDE POLYMORPHISMS; TUMOUR PROGRESSION;

DISEASES;

EID: 84912575005     PISSN: 13102818     EISSN: None     Source Type: Journal    
DOI: 10.1080/13102818.2014.965047     Document Type: Article

References (18)

1. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 2005;7:211-217.
2. Szlosarek P, Charles KA, Balkwill FR. Tumour necrosis factor-alpha as a tumour promoter. Eur J Cancer. 2006;42:745-750.
3. Monteleone G, Pallone F, Stolfi C. The dual role of inflammation in colon carcinogenesis. Int J Mol Sci. 2012;13:11071-11084.
4. Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9:361-371.
5. Terzi-c J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology. 2010;138:2101-2114.
6. Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 2002;13:135-141.
7. Bertazza L, Mocellin S. The dual role of tumor necrosis factor (TNF) in cancer biology. Curr Med Chem. 2010;17:3337-3352.
8. Grimm M, Lazariotou M, Kircher S, Höfelmayr A, Germer CT, von Rahden BHA, Waaga-Gasser AM, Gasser M. Tumor necrosis factor-a is associated with positive lymph node status in patients with recurrence of colorectal cancer- indications for anti-TNF-a agents in cancer treatment. Cell Oncol. 2010;33:151-163.
9. Sharma R, Zucknick M, London R, Kacevska M, Liddle C, Clarke S. Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer. Clin Colorectal Cancer. 2008;7:331-337.
10. Abraham L, Kroeger K. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol. 1999;66:562-566.
11. Ding B, Fu S, Wang M, Yue C, Wang W, Zhou D, Zhang Z, Han S. Tumor necrosis factor alpha -308 G>A polymorphisms and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer. 2012;22:213-219.
12. Fang F, Yao L, Yu XJ, Yu L, Wu Q, Yu L. TNFalpha-308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls. Breast Cancer Res Treat. 2010;122:267-271.
13. Fan W, Maoqing W, Wangyang C, Fulan H, Dandan L, Jiaojiao R, Xinshu D, Binbin C, Yashuang Z. Relationship between the polymorphism of tumor necrosis factora- 308 G>A and susceptibility to inflammatory bowel diseases and colorectal cancer: a meta-analysis. Eur J Hum Genet. 2011;19:432-437.
14. Landi S, Moreno V, Gioia-Patricola L, Guino E, Navarro M, de Oca J, Capella G, Canzian F, Bellvitge Colorectal Cancer Study Group. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor a, NFKB1, and peroxisome proliferatoractivated receptor g with colorectal cancer. Cancer Res. 2003;63:3560-3566.
15. Park KS, Mok JW, Rho SA, Kim JC. Analysis of TNFB and TNFA Ncol RFLP in colorectal cancer. Mol Cells. 1998;8:246-249.
16. Theodoropoulos G, Papaconstantinou I, Felekouras E, Nikiteas N, Karakitsos P, Panoussopoulos D, Ch Lazaris A, Patsouris E, Bramis J, Gazouli M. Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol. 2006;12:5037-5043.
17. Hristova M, Dourmishev L, Kamenarska Z, Kaneva R, Vinkov A, Mitev V. Association of tumor necrosis factor a (TNF-a) and interleukin 10 (IL-10) gene polymorphisms in dermatomyositis patients: a pilot study. Acta Dermatovenerol Croat. 2012;20:148-156.
18. Kim S, Keku TO, Martin C, Galanko J, Woosley JT, Schroeder JC, Satia JA, Halabi S, Sandler RS. Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res. 2008;68:323-328.